Segui
Boris Turk
Boris Turk
Professor of Biochemistry, Head of Department of Biochemistry and Molecular and Structural Biology
Email verificata su ijs.si
Titolo
Citata da
Citata da
Anno
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, DJ (Klionsky, FC Abdalla, FC (Abdalla, ...
Autophagy 8 (4), 445-544, 2012
13457*2012
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
53242018
Targeting proteases: successes, failures and future prospects
B Turk
Nature reviews Drug discovery 5 (9), 785-799, 2006
16832006
Cysteine cathepsins: from structure, function and regulation to new frontiers
V Turk, V Stoka, O Vasiljeva, M Renko, T Sun, B Turk, D Turk
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1824 (1), 68-88, 2012
14942012
Lysosomal cysteine proteases: more than scavengers
B Turk, D Turk, V Turk
Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular …, 2000
11292000
Lysosomal cysteine proteases: facts and opportunities
V Turk, B Turk, D Turk
The EMBO journal, 2001
10192001
Lysosomal protease pathways to apoptosis: cleavage of Bid, not pro-caspases, is the most likely route
V Stoka, B Turk, SL Schendel, TH Kim, T Cirman, SJ Snipas, LM Ellerby, ...
Journal of Biological Chemistry 276 (5), 3149-3157, 2001
8692001
Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
B Turk, V Turk, D Turk
Biological chemistry 378 (3-4), 141-150, 1997
6391997
Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins
T Cirman, K Orešić, GD Mazovec, V Turk, JC Reed, RM Myers, ...
Journal of Biological Chemistry 279 (5), 3578-3587, 2004
5982004
Emerging roles of cysteine cathepsins in disease and their potential as drug targets
O Vasiljeva, T Reinheckel, C Peters, D Turk, V Turk, B Turk
Current pharmaceutical design 13 (4), 387-403, 2007
5622007
Lysosomes and lysosomal cathepsins in cell death
U Repnik, V Stoka, V Turk, B Turk
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1824 (1), 22-33, 2012
4572012
Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues
G Droga-Mazovec, L Bojic, A Petelin, S Ivanova, U Repnik, GS Salvesen, ...
Journal of Biological Chemistry 283 (27), 19140-19150, 2008
4362008
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment
G Mikhaylov, U Mikac, AA Magaeva, VI Itin, EP Naiden, I Psakhye, ...
Nature nanotechnology 6 (9), 594-602, 2011
4282011
Cysteine cathepsins and extracellular matrix degradation
M Fonović, B Turk
Biochimica et Biophysica Acta (BBA)-general subjects 1840 (8), 2560-2570, 2014
3662014
Protease signalling: the cutting edge
B Turk, D Turk, V Turk
The EMBO journal 31 (7), 1630-1643, 2012
3412012
Lysosomal cathepsins and their regulation in aging and neurodegeneration
V Stoka, V Turk, B Turk
Ageing research reviews 32, 22-37, 2016
3392016
Lysosomes as “suicide bags” in cell death: myth or reality?
B Turk, V Turk
Journal of Biological Chemistry 284 (33), 21783-21787, 2009
3282009
Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators
B Turk, D Turk, GS Salvesen
Current pharmaceutical design 8 (18), 1623-1637, 2002
3242002
Cysteine cathepsins and their extracellular roles: shaping the microenvironment
E Vidak, U Javoršek, M Vizovišek, B Turk
Cells 8 (3), 264, 2019
3122019
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases
D Turk, V Janjić, I Štern, M Podobnik, D Lamba, SW Dahl, C Lauritzen, ...
The EMBO journal, 2001
3122001
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20